<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Concentrates of antithrombin III (AT III) have been applied in congenital as well as in acquired AT III deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>Congenital defects only require substitution during surgery and in the case of pregnancy </plain></SENT>
<SENT sid="2" pm="."><plain>Otherwise prophylaxis of <z:mp ids='MP_0005048'>thrombosis</z:mp> can be successfully carried out with oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>In acquired AT III deficiency substitution was found to be useful in cases of advanced <z:chebi fb="0" ids="53092">DIC</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>When AT III activity was constantly kept around 100% the duration of <z:chebi fb="0" ids="53092">DIC</z:chebi> could be considerably shortened </plain></SENT>
<SENT sid="5" pm="."><plain>No beneficial effect of additional administration of <z:chebi fb="5" ids="28304">heparin</z:chebi> was found </plain></SENT>
<SENT sid="6" pm="."><plain>In cases of <z:chebi fb="0" ids="53092">DIC</z:chebi> due to septic shock the survival rate could be increased from an average of 20% without substitution to over 70% with AT III substitution as could be shown by different authors </plain></SENT>
</text></document>